Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment: a prospective cohort study

Autor: Lee W. Riley, Ethel Leonor Noia Maciel, Mauro Niskier Sanchez, Christian Lienhardt, Susan Martins Pereira, Gleide Santos de Araújo, Carolina Maia Martins Sales, Barbara Reis-Santos, Kaio Vinicius Freitas de Andrade, Kerollen Cristina da Silva da Silva, Janaina Gomes Gomes Nascimento Oliosi, Rodrigo Leite Locatelli, Walter Gomes da Silva Filho, Priya B. Shete
Přispěvatelé: Federal University of Espírito Santo, Universidade de Brasilia [Brasília] (UnB), Universidade Estadual de Feira de Santana, Universidade Federal da Bahia (UFBA), University of California [San Francisco] (UCSF), University of California, University of California [Berkeley], Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques er émergentes (TransVIHMI), Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Université Montpellier 1 (UM1), Université de Montpellier (UM), Brazilian National Council for Scientific and Technological Development (CNPq) and Brazilian Ministry of Health Department of Science and Technology (DECIT)., Universidade Estadual de Feira de Santana [Bahia]=State University of Feira de Santana (UEFS), University of California [San Francisco] (UC San Francisco), University of California (UC), University of California [Berkeley] (UC Berkeley), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: The Lancet global health
The Lancet global health, Elsevier, 2019, 7 (2), pp.e219-e226. ⟨10.1016/S2214-109X(18)30478-9⟩
The Lancet global health, 2019, 7 (2), pp.e219-e226. ⟨10.1016/S2214-109X(18)30478-9⟩
ISSN: 2214-109X
Popis: International audience; BACKGROUND: Social protection interventions might improve tuberculosis outcomes and could help to control the epidemic in Brazil. The aim of this study was to evaluate the independent effect of the Bolsa Familia Programme (BFP) on tuberculosis treatment outcomes in Brazil.METHODS: We prospectively recruited and followed up individuals (aged ≥18 years) who initiated tuberculosis treatment at 42 health-care centres across seven cities in Brazil, between March 1, 2014, and April 30, 2017. Patients were interviewed at health-care centres and information about individual characteristics, socioeconomic status, living conditions, lifestyle, and comorbidities was recorded. Patients were separated into two groups according to BFP beneficiary status: BFP (exposed) or non-BFP (not exposed). Treatment outcome (cure, dropout, death, or development of drug-resistant tuberculosis or treatment failure) was recorded after 6 months of therapy. Pearson's χ2 test and ANOVA were used to compare tuberculosis treatment outcomes between the two groups, and we estimated the propensity score of being a beneficiary of the BFP using a logit model. We used multinomial regression models to evaluate the effect of the BFP on tuberculosis treatment outcomes.FINDINGS: 1239 individuals were included in the study, of whom 196 (16%) were beneficiaries of the BFP and 1043 (84%) were not. After 6 months of treatment, 912 (87%) of 1043 patients in the non-BFP group and 173 (88%) of 196 patients in the BFP group were cured of tuberculosis, 103 (10%) patients in the non-BFP group and 17 (9%) patients in the BFP group had dropped out, and 25 (3%) patients in the non-BFP group and six (3%) patients in the BFP group had died. Three (
Databáze: OpenAIRE
Externí odkaz: